Express News | The USA Biological Security Act was not included in the CR bill.

BreakingsDec 18 15:53

The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!

Industry pessimistic expectations may improve.

Gelonghui FinanceDec 9 12:10

How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.

① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.

cls.cnDec 8 16:48

Jiahe Biological-B (06998.HK): somerley cap has been appointed as the independent financial advisor.

On November 26, Glorious News announced that the board of directors of Jiahe Biological-B (06998.HK) is pleased to announce that Somerley Cap, a corporation licensed to conduct regulated activities under the Securities and Futures Ordinance for Type 1 (trade in securities) and Type 6 (advising on corporate finance), has been appointed as an independent financial advisor to provide advice on (i) the retention plan for Wong and the voting actions of the Listing Rules Independent Board Committee and independent shareholders; and (ii) the proposed merger, cleansing exemption, and shareholder personnel retention plan (including Wong's retention plan) as well as the voting actions before the Takeovers Code Independent Board Committee.

Gelonghui FinanceNov 26 22:50

Jiahe Biology-B (06998) has appointed somerley cap as its independent financial advisor.

Jiahua Biotechnology-B (06998) announced that Somerley Cap Limited (a company licensed under the Securities and Futures Ordinance to...)

Zhitong FinanceNov 26 22:49

This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?

According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.

Securities TimesNov 26 19:39